Yelena Bronevetsky, PhD, lays out the current challenges in tumor antigen discovery and how our Opto™ Antigen Presenting Bead Kit helps scientists overcome them.
Dr. David Barrett shares insights into why children’s T cells help CAR-T cells succeed and discusses how the Opto Cell Therapy Development Workflow can provide the detailed characterization required to develop more efficacious therapies.
See how you can rapidly visualize and analyze thousands of cell-cell interactions in a single-day workflow with live cell recovery.
Learn how to track the kinetics of T cell-tumor cell killing behavior in real time.